Neuroone Medical Technologies Corp reports results for the quarter ended in December - Earnings Summary

Neuroone Medical Technologies

14/02/2023 21:54

* Neuroone Medical Technologies Corp  NMTC.OQ  reported a
quarterly adjusted loss of 11 cents​​ per share for the quarter
ended in December. The mean expectation of two analysts for the
quarter was for a loss of 11 cents per share.
    * Revenue rose 240.7% to $115.00 thousand from a year ago;
analysts expected $1.90 million. 
    * Neuroone Medical Technologies Corp's reported EPS for the
quarter was a loss of 11 cents​.
    * The mean earnings estimate of analysts had risen by
about 53.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Neuroone Medical Technologies Corp shares had risen
by 71.7%
this quarter.
    * The company reported a quarterly loss of $1.73 million.
    * Wall Street's median 12-month price target for Neuroone
Medical
Technologies Corp is $2.63 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
14 at 09:54 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.11          Met
 Sep. 30 2022      -0.11          -0.09          Beat
 Jun. 30 2022      -0.22          -0.17          Beat
 Mar. 31 2022      -0.20          -0.19          Beat